Cargando…

Elevated serum levels of human epididymis protein 4 in adult patients with proliferative lupus nephritis

BACKGROUND: This study aimed to access whether serum human epididymis protein 4 (HE4) level could identify lupus nephritis (LN) pathological classes in adults and children. METHODS: The serum HE4 levels of 190 healthy subjects and 182 patients with systemic lupus erythematosus (SLE) (61 adult-onset...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Liubing, Xu, Huiya, Le, Yuting, Li, Runzhao, Shi, Qiong, Zhu, Hongji, Xu, Hongxu, Li, Laisheng, Liu, Min, Wang, Fen, Zhang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243370/ https://www.ncbi.nlm.nih.gov/pubmed/37287983 http://dx.doi.org/10.3389/fimmu.2023.1179986

Ejemplares similares

Anti-DFS70 Antibodies Are Associated With Proliferative Lupus Nephritis and Renal Pathological Activity
por: Chen, Dandan, et al.
Publicado: (2022)

Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus
por: Zhang, Yamei, et al.
Publicado: (2022)

Molecular characterization of proliferative lupus nephritis
por: Parikh, Samir V, et al.
Publicado: (2014)

Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages
por: Zhang, Ting, et al.
Publicado: (2020)

Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine lupus nephritis
por: Ijima, Shogo, et al.
Publicado: (2022)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren’s Syndrome
por: Chen, Jiali, et al.
Publicado: (2021)

A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis
por: Chen, Dong-Ni, et al.
Publicado: (2018)

Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis
por: Soliman, Samar A., et al.
Publicado: (2022)

Urine and serum interleukin 35 as potential biomarkers of lupus nephritis
por: Nassif, Mary Atef
Publicado: (2021)

Rescue treatment of severe lupus myocarditis and proliferative lupus nephritis with immunoadsorption
por: Štambuk, Sandra Karanović, et al.
Publicado: (2023)

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011)

Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis
por: Romick-Rosendale, Lindsey E, et al.
Publicado: (2011)

Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus
por: He, Jingquan, et al.
Publicado: (2022)

Mesangial cell: A hub in lupus nephritis
por: Liu, Mengdi, et al.
Publicado: (2022)

The Involvement of the Chemokine RANTES in Regulating Luminal Acidification in Rat Epididymis
por: Feng, Xiao, et al.
Publicado: (2020)

Treatment of refractory lupus nephritis using leflunomide: A prospective study
por: Zhang, Shuo, et al.
Publicado: (2023)

Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis
por: Olson, S. W., et al.
Publicado: (2017)

Immunomodulatory Activity of Mesenchymal Stem Cells in Lupus Nephritis: Advances and Applications
por: Li, Jicui, et al.
Publicado: (2022)

A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis
por: Fu, Wenyan, et al.
Publicado: (2021)

CRAC Channel Controls the Differentiation of Pathogenic B Cells in Lupus Nephritis
por: Li, Xue, et al.
Publicado: (2021)

Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022)

Discovery of Novel Circulating Immune Complexes in Lupus Nephritis Using Immunoproteomics
por: Tang, Chenling, et al.
Publicado: (2022)

Corrigendum: A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis
por: Fu, Wenyan, et al.
Publicado: (2021)

High-Throughput Sequencing-Based Analysis of T Cell Repertoire in Lupus Nephritis
por: Ye, Xiaolan, et al.
Publicado: (2020)

Corrigendum: Urine soluble CD163 is a promising biomarker for the diagnosis and evaluation of lupus nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022)

Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients
por: Daamen, Andrea R., et al.
Publicado: (2023)

The protective capability of Hedyotis diffusa Willd on lupus nephritis by attenuating the IL-17 expression in MRL/lpr mice
por: Li, Ying, et al.
Publicado: (2022)

Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis
por: Gonzalo, Elena, et al.
Publicado: (2012)

Differing environmental risk factors for membranous versus proliferative lupus nephritis
por: Dooley, MA, et al.
Publicado: (2012)

The Steroids In the Maintenance of remission of Proliferative Lupus nephritis (SIMPL) pilot trial
por: Galbraith, Lauren, et al.
Publicado: (2014)

Hydroxychloroquine in children with proliferative lupus nephritis: a randomized clinical trial
por: Gheet, Fatma Sayed, et al.
Publicado: (2023)

Long-term renal outcomes of patients with non-proliferative lupus nephritis
por: Kang, Eun-Song, et al.
Publicado: (2023)

Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis
por: Chen, Shanshan, et al.
Publicado: (2023)

Myeloid-Derived Suppressor Cells Induce Podocyte Injury Through Increasing Reactive Oxygen Species in Lupus Nephritis
por: Zhang, Dongya, et al.
Publicado: (2018)

Developing consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous
por: Mina, Rina, et al.
Publicado: (2012)

Lupus nephritis in children – 10 years’ experience
por: Szymanik-Grzelak, Hanna, et al.
Publicado: (2016)

Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study
por: Lu, Xinxia, et al.
Publicado: (2023)

Biomarkers Associated with Drugs for the Treatment of Lupus Nephritis
por: Nie, Huiyu, et al.
Publicado: (2023)

Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis
por: Bejar, Jacob, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6urc8uc9hg5msrs7pdgd5jf3p0